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The human placenta is a diﬃcult tissue to work with using proteomic technology since it contains large amounts of lipids
and glycogen. Both lipids and glycogen are known to interfere with the ﬁrst step in the two-dimensional polyacrylamide gel
electrophoresis (2D-PAGE), the isoelectric focusing. In order to gain the best possible protein separation on 2D-PAGE, an
optimized sample preparation protocol for placental proteins was developed. Two diﬀerent buﬀers, urea/CHAPS and Hepes,
were used for solubilization in combination with six diﬀerent precipitation methods. The removal of glycogen from the
samples by centrifugation was crucial for the ﬁnal proteome maps. Solubilization with urea/CHAPS in combination with
dichloromethane/methanol or acidiﬁed acetone proved to be the best precipitation procedures. When applied to clinical placenta
samples apolipoprotein A1 was found to be accumulated in the preeclamptic placenta, where it may either have a nutritional eﬀect
or act as a modiﬁer of signal transduction.
1.Introduction
The human placenta is unique among species. As a matter
of fact, of all mammalian organs the placenta shows the
greatestvariationintermsofanatomy.However,inallspecies
ithasthesamefundamentalfunction,tonourishthegrowing
fetus, by establishing contact with the maternal blood
circulation [1]. In addition, the placenta acts as a protective
barrier; as an example it prevents stress hormones to pass
over to the fetus via active transport [2]. In order to prevent
rejection of the fetus, the placenta expresses an intricate
pattern of major histocompatibility complex molecules,
immunizing the mother against the foreign fetal tissue [3].
During pregnancy the placenta also has several important
endocrine functions, producing important hormones such
as human chorionic gonadotropin and human placental
lactogen [4, 5]. Hence, due to its vast number of functions
the placenta expresses more than 20 000 DNA sequences
and is perhaps the organ expressing the largest number of
genes [6]. In fact, it has been used as a “ﬁshing pond” for
ﬁnding and sequencing new genes and has been used to
identifyandclonetransportersandreceptors,suchashuman
growth hormone-variants, integrin alpha V, and subtypes of
the angiotensin receptors [7–9].
Preeclampsia (PE) is a pregnancy associated disorder
characterizedbyhypertensionandproteinuria.Itaﬀects3%–
7% of all pregnancies [10] and is a major cause of maternal
and fetal mortality. Treatment for PE is symptomatic, and
removal of the placenta is the only curative treatment,
suggesting that the placenta is a key in the development of
PE. The etiology of PE is still largely unknown; however,
it is generally accepted that PE begins with inadequate
placentation. Invasion of placental trophoblast cells into the
maternal spiral arteries is too shallow, leading to inadequate
placental perfusion and hypoxia [11, 12].
Proteomics is a research ﬁeld undergoing rapid develop-
ment, especially in regards to the methods being used. The
most common method is two-dimensional polyacrylamide
gel electhrophoresis (2D-PAGE). 2D-PAGE for proteome
studies gives a map of proteins which reﬂect changes in2 Journal of Biomedicine and Biotechnology
protein expression levels, as well diﬀerent isoforms and
posttranslational modiﬁcations. Lately, three types of pro-
tein microarrays have become available, namely, analyti-
cal microarrays, functional microarrays, and reverse phase
microarrays (reviewed in [13]). Highly sensitive and speciﬁc
recombinant antibody microarrays allowing screening of
crude protein extracts are also being developed [14]. Due
to the large number of proteins, no protein array platform
has yet been designed that covers the entire human placental
proteome. Thus, when screening the placental proteome
2D-PAGE is still among the most accepted methods giv-
ing the highest coverage although this may soon change.
However, there are several obstacles when working with
placental tissue, since it contains large amounts of lipids
and glycogen [15]. In order for the ﬁrst dimension, iso-
electric focusing (IEF), to be successful, proteins have to
be eﬃciently extracted, and solubilized, and contaminants,
such as lipids, polysaccharides, nucleic acids, and salt ions,
must be removed. Lipids, polysaccharides and nucleic acids
bind to proteins which increases the viscosity of the samples
and often results in horizontal streaking on the 2D-PAGE.
If the salt concentration is too high in the sample, the
conductivityin the IPG strips increases and prolongs the IEF,
resulting in poor 2D-PAGE resolution. These contaminants
can be removed by precipitation of the solubilized samples.
Unfortunately, there is no universal precipitation method
that removes all the diﬀerent contaminants. For example,
precipitating samples with dichloromethane/methanol has
been described to remove lipids whereas precipitation with
ethanol will remove nucleic acids [16]. For these reasons, the
placenta proteome is not fully investigated although some
progress has been made in the use of proteomics technology
to study PE placenta [17, 18].
The primary aim of this study was to establish a
robust sample preparation protocol of human placental
tissue, by comparing two diﬀerent solubilization solutions in
combination with six diﬀerent precipitation methods.
2.MaterialandMethods
2.1. Tissue Samples. Sixty women admitted at the Depart-
ment of Obstetrics and Gynecology, Lund University Hos-
pital, were included and assigned to two groups: PE (n =
30) and control (n = 30) (Table 1). All women gave their
written informed consent. PE was deﬁned as blood pressure
above 140/90mmHg and proteinuria above 0.3g/L or rise
in blood pressure above 20mmHg from the ﬁrst trimester
of pregnancy [19]. No women in the control group suﬀered
PE in a previous pregnancy. Patients were matched based
on gestational age. A 10mm cube of placenta tissue was
collected immediately after removal of the placenta and was
frozen on dry ice and stored at −80
◦C. Patients with other
systemic diseases were excluded from the study. This study
was approved by the Ethical Committee Review Board for
studies in human subjects at Lund University.
2.2.ProteinExtraction. Humanplacentaltissueswerepulver-
ized, and the frozen placental powder (25mg frozen weight)
washomogenizedwithalysissolutioncontainingeither3mL
Table 1: Clinical characteristics of the patients participating in this
study. Age and Gestational length are expressed as median (range),
and the other values as mean ± standard deviation.
Controls PE
n 30 30
Age (years) 32 (23–44) 30 (22–45)
Gestational length (days) 269 (247–295) 265 (235–287)
Systolic MAP (mmHg) 116 ±11.3 150 ±12.1
Diastolic MAP (mmHg) 67 ±4.4 103 ±7.9
Albumin (g/l) ND 1.9 ±1.4
Placenta weight (g) 687 ± 144 631 ±128
Child gender (M : F) 19 : 11 15 : 15
Child weight (g) 3671 ±297 3219 ± 571a
ND:n o td e t e c t e d ,M:m a l e ,F:f e m a l e .
aStudent two-tailed unpaired t-test showed a signiﬁcant diﬀerence between
the control and the PE group: P< . 0002.
8Mu r e aa n d2 %C H A P So r3m Li c ec o l d1 0m MH e p e s ,
pH 7.5, 24mM KCl supplemented with a protease inhibitor
cocktail (Complete mini plus EDTA, Roche, Basel, Switzer-
land) [20]. Samples were stirred for 1 hour followed by
centrifugationat43000gfor2hours.Proteinconcentrations
were determined by the bicinchoninic acid (BCA) method
(Thermo Scientiﬁc, Rockford, USA) with bovine serum
albumin (BSA) as a standard. Pooled samples were prepared
by combining equal amounts of proteins from individual
samples. The pooled samples were either used directly (fresh
samples) or stored at −80
◦C prior to use (frozen samples).
The individual samples were stored at −80
◦C.
2.3. Protein Precipitation Procedures. Proteins were precipi-
tated according to the following procedures. For 1D-PAGE,
30μg were precipitated, and for small and large 2D-PAGE,
100μg and 500μg were precipitated, respectively.
Acetone. E x t r a c t e ds a m p l e sw e r em i x e dw i t hi c e - c o l da c e -
tone to ﬁnal concentration of 80% acetone. Samples were
incubated overnight at −20
◦C followed by centrifugation at
9000g for 2minutes. The supernatant was removed, and the
protein pellets were allowed to air dry.
Acidiﬁed Acetone. Samples were precipitated as above, but
the acetone was acidiﬁed with acetic acid to a ﬁnal concen-
tration of 0.05%.
Ethanol. Ten volumes of ice-cold ethanol were added to one
volume of sample. Samples were centrifuged as above, and
the protein pellets were allowed to air-dry.
Dichloromethane/Methanol. Samples were precipitated as
previously described [16]. Brieﬂy, one volume of sample
was mixed with 4 volumes of methanol, 2 volumes of
dichloromethane, and 3volumes of distilled water. The
samples were mixed between each addition. The samples
were centrifuged 9000g for 2minutes at room temperature
(RT). The supernatant was discarded, and 3 volumes of
methanol were added followed by mixing. The samples wereJournal of Biomedicine and Biotechnology 3
centrifuged at 9000g for 2minutes and the supernatant was
again discarded after which pellets were air dried.
Trichloroacetic Acid (TCA). One volume of 40% TCA was
added to one volume of samples and incubated for 1hour on
ice followed by centrifugation at 9000g for 2minutes. The
supernatant was removed, and the protein pellets were either
directly dried or washed with ethanol and then allowed to air
dry. The dried pellets were either dissolved in 30μLs o d i u m
dodecyl sulphate (SDS) sample buﬀer pH 8.5 (247mM Tris,
2% SDS, 0.5mM edetate (EDTA), 16.5mM dithiothreitol
(DTT), 10% glycerol, and 0.025% (w/v) bromophenol blue)
followed by 1D-PAGE or dissolved in rehydration sample
buﬀer containing 8M Urea, 2% CHAPS, 10mM DTT, and
2% 3–10NL ampholines (GE Healthcare, Little Chalfont,
UK).
2.4. 1D-PAGE. Samples (30μg) were loaded onto 10-well
4%–12% NuPAGE Bis-Tris gels (Invitrogen, Carlsbad, USA)
and run at 200V for 45minutes using 2-(N-morpholino)
ethanesulfonic acid (MES) as running buﬀer. Proteins were
visualized by staining with Coomassie Brilliant Blue (R-350).
2.5. 2D-PAGE. The ﬁrst dimensional isoelectric focusing
(IEF) was performed on a horizontal Multiphor (Amersham
Biosciences, USA). Immobilized pH gradient (IPG) Blue
native strips 3–10NL (0.5×3×70mm or 0.5×3×240mm)
(SERVA Electrophoresis GmbH, Heidelberg, Germany) were
in-gel rehydrated in rehydration sample buﬀer over night.
For 7cm strips, 130μL (containing 100μg of proteins) and
for 24cm strips, 450μL (containing 500μg of proteins)
rehydration sample buﬀer were used. The focusing was
performed at the following voltage gradients: 150V for
30minutes, 300V for 30minutes, 600V for 30minutes,
1500V for 1.5hours, 3000V for 2hours (7cm strips) and
25hours (24cm strips). The strips were equilibrated for
10minutes in a solution containing 65mM DTT, 6M urea,
30% (w/v) glycerol, 2% (w/v) SDS and 50mM Tris-HCl
pH 8.8. A second equilibration step was performed for
10minutes in the same solution except for DTT, which was
replaced by 259mM iodoacetamide. The strips were soaked
in electrophoresis buﬀer (24mM T ris base, 0.2M Glycine
and 0.1% SDS) just before the second dimensional gel elec-
trophoresis. The strips were applied on 12% homogeneous
Tris-glycine gels (0.1 × 8 × 8cmor0.1 × 20 × 24cm) and
overlaid with a solution of 1% agarose in electrophoresis
buﬀer (kept at 60
◦C). Electrophoresis was carried out in an
XCell Mini-cell apparatus (Invitrogen) using electrophoresis
buﬀer at 125V for 1.5hours or in an Hoefer DALT gel
apparatus (GE Healthcare) at 20
◦C and constant 80V for
19hours.
Gel Staining. Gels were either stained with silver [21]o r
stained with SYPRO Ruby (Thermo Scientiﬁc).
Image Analysis. S m a l lg e l sw e r es c a n n e du s i n gaC a n o S c a n
995OF (Canon, Solna, Sweden), and large gels were scanned
using an Amersham Typhoon 9400 (GE Healthcare). The
images of the large gels stained with SYPRO Ruby were
submitted to Ludesi 2D Analysis (Ludesi, Malmo, Sweden,
http://www.ludesi.com) for spot detection, matching, and
analysis.
Peptide Mass Fingerprinting. The spots of interest were
washed and digested as previously described [22]. The
puriﬁed peptides were eluted directly onto the sample
target (Anchorchip target, Bruker Daltonik GmbH, Bremen,
Germany)where0.7μLofmatrix,2,5-dihydroxybenzoicacid
(10mg/ml in 30% ACN) had been added. Mass spectra of
p o s i t i v e l yc h a r g e di o n sw e r er e c o r d e do naB r u k e rR e ﬂ e x
III instrument (Bruker Daltonik) operated in the reﬂector
mode. A total of 160–210 single shot spectra were accumu-
lated from each sample. The XMASS 5.0 and MS Biotools
software packages provided by the manufactures were used
for data processing. Known autoproteolysis products from
the trypsin were used for internal calibration.
Database Searching. For protein identiﬁcation, human pro-
tein sequences in the SwissProt database were searched using
the Mascot Software (Matrix Science Ltd., London, UK).
Parameters speciﬁed in the search were taxa, Homo Sapiens;
missed cleavages, 1; peptide mass tolerance +/0.1 Da; ﬁxed
modiﬁcation, carbamidomethyl (C); variable modiﬁcation,
oxidized methionine.
2.6.WesternBlot. Proteinswereseparatedby1D-PAGEusing
10-well 12% NuPAGE Bis-Tris gels (Invitrogen) according
to manufacturer’s instruction. The gels were loaded with
2.5μg protein per well and run for 60minutes at 200V
in MOPS running buﬀer under reduced conditions and
blotted onto polyvinylidene ﬂuoride (PVDF) membranes
for 8minutes at 23V using an iBlot dry blotting system
(Invitrogen). Membranes were incubated with primary anti-
body for 1hour (mouse monoclonal anti-APOA1, sc-69755,
1 : 2000dilution), followed by washes and then, incubated
with the secondary antibody for 1hour (goat polyclonal
antimouse IgG, sc-2031, 1 : 5000dilution). Antibodies were
obtained from Santa Cruz (Santa Cruz Biotechnology, Santa
Cruz, USA). Subsequently, the membrane was exposed
to Enhanced chemilumeniscence ECL+ (GE Healthcare)
for 3minutes. Autoradiographic ﬁlm Hyperﬁlm ECL (GE
Healthcare) was applied to the blot for various durations
to obtain satisfactory exposure. When developed, ﬁlms were
scanned with ultra violet light using a Gene Flash scanner
(Syngene, Cambridge, UK) and imported into Syngene Gene
Tools. One reference sample was added to all gels to serve
as an internal calibrator to normalize the quantiﬁcation
between gels. A students t-test was used to determine
statistical diﬀerence between the two groups. A P-value <. 05
was considered statistically signiﬁcant.
2.7. Immunohistochemistry. Immunohistochemistry was
performed using EnVision+System-HRP (DakoCytomation,
Carpinteria, USA) on 4 representative PE samples and
4 controls according to the manufacturer’s instructions.
Brieﬂy, fresh frozen sections, 12μm thick, of the placenta4 Journal of Biomedicine and Biotechnology
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Figure 1: 1D-PAGE comparing solubilization and precipitation methods. (a) One-dimensional separation of proteins in PE placenta
solubilized in Hepes buﬀer before and after centrifugation at 43 000g. From left to right: Mw Precision standard marker, starting material
(30μg), supernatant after centrifugation (30μg), and pellet after centrifugation. The gel was stained with Coomassie Brilliant blue. (b) One-
dimensional separation of proteins in PE placenta solubilized in urea/CHAPS solution and (c) Hepes buﬀer. The lanes are from left to right:
MW precision standard markers, starting material, and precipitations with acetone, acidiﬁed acetone, ethanol, dichloromethane/methanol,
TCA, and TCA followed by ethanol wash. Bands indicated with numbers were identiﬁed by MALDI-TOF MS (Table 2).
Table 2: Proteins identiﬁed using MALDI-TOF MS.
Protein Acc. No Mw Matched Score Seq. Cov
(kDa) peaks (%)
Band 1 Annexin A1 P04083 38.9 18 117 59
Annexin A2 P07355 38.8 20 92 45
Glyceraldehyd-3-phosphate dehydrogenase P04406 36.2 13 59 41
Band 2 Endoplasmin P14625 92.7 15 99 19
Band 3
Keratin, type I cytoskeletal 18 P05783 48.0 22 142 37
Keratin, type II cytoskeletal 8 P05787 53.7 15 77 26
Vimentin P08670 53.7 28 207 52
Band 4 Hemoglobin subunit gamma-1 P69891 16.2 8 86 42
Hemoglobin subunit gamma-2 P69892 16.2 9 81 51
Band 5
Hemoglobin subunit alpha P69905 15.3 6 66 53
Hemoglobin subunit gamma-1 P69891 16.2 8 78 46
Hemoglobin subunit gamma-2 P69892 16.2 8 78 46
Band 6 Hemoglobin subunit alpha P69905 15.3 8 72 59
Spot PE Apolipoprotein A1 P02647 30.7 7 76 26
Spot Ctl Tropomyosin alpha-3 chain P06753 32.9 9 63 26
samples were ﬁxed by immersion in 4% phosphate buﬀered
saline (PBS) buﬀered formaldehyde for 15minutes at RT.
Sections were incubated in a blocking solution containing
3% H2O2 for 10minutes at RT. The APOA1 antibody was
diluted (0.1μg/mL) in PBS containing 0.25% Triton X100
and 1.5% normal goat serum. Sections were incubated over
night at 4◦C after which the sections were rinsed. Peroxidase
labeled polymer was applied to cover the specimens and
then incubated for 30minutes. After rinsing the sections,
LiquidDAB substrate chromogen solution was applied and
incubated for 8minutes. The sections were rinsed and
stained with Mayers hematoxylin after which sections were
mounted with Mountex (Histolab, Gothenburg, Sweden)
and cover slipped. Sections were viewed under an Olympus
BX-60 microscope and images captured using an Olympus
DP50CU digital camera (Olympus America Inc., Center
Valley, USA).
3. Results
3.1.SolubilizationandPrecipitation. Twosolubilizationsolu-
tionswerechosen:Hepesbuﬀer[20]andthecommonlyused
urea/CHAPS. A centrifugation step was added to remove
contaminants such as glycogen and cell debris. The pellet
resulted in smearing on 1D-PAGE (Figure 1(a)) and without
the centrifugation step; no proteins entered the IEF-strip
resulting in a blank 2D-PAGE (data not shown). There
were no obvious diﬀerences in protein patterns between
the supernatant and the starting material (Figure 1(a)). 1D-
PAGE separation was used to determine protein expressionJournal of Biomedicine and Biotechnology 5
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Figure 2: Two-dimensional separation of precipitated proteins (100μg) in PE placenta solubilized in (a) urea/CHAPS and (b) Hepes buﬀer.
Precipitation procedures (1) dichloromethane/methanol, (2) TCA, (3) TCA followed by ethanol wash, (4) acetone, (5) acidiﬁed acetone, and
(6) ethanol. The gels were stained with silver. Arrows on lower right image represent directions for increasing Mw and pI. Directions are the
same for all gels.
from the two diﬀerent solubilization solutions. A major
diﬀerence in the protein pattern between Hepes buﬀer
and urea/CHAPS was obtained in the low molecular mass
range. Minor diﬀerences at higher molecular mass range
are also obtained when comparing the two diﬀerent sol-
ubilization solutions (Figures 1(b) and 1(c)). A number
of the protein bands that visibly diﬀered between the two
solubilization solutions were identiﬁed using MALDI-TOF
MS. The obtained identities included annexin A1, annexin
A2, endoplasmin, vimentin, and hemoglobin subunit alpha
and gamma (Table 2). Some of the bands from the 1D-PAGE
contained more than one identity due to the limited power
of resolution using 1D-PAGE.
Six diﬀerent precipitation procedures were tested: ace-
tone, acidiﬁed acetone, ethanol dichloromethane/methanol,
TCA, and TCA followed by ethanol wash. To determine
the eﬀects of precipitation procedures on protein pat-
terns, precipitated samples were analyzed on 1D-PAGE gels
(Figures 1(b) and 1(c)). Samples precipitated with TCA,
with or without ethanol wash, showed a diﬀerent protein
expression proﬁle compared to the other four precipita-
tion methods. No signiﬁcant diﬀerences in the 1D-PAGE
expression proﬁles were detected between the other four
precipitation procedures (acetone, acidiﬁed acetone, ethanol
and dichloromethane/methanol).
3.2. 2D-PAGE. Samples solubilized with urea/CHAPS gen-
erally resulted in more protein spots and less horizontal
streaking, regardless of precipitation procedure (Figure 2).
The investigation of whether freezing of solubilized and cen-
trifugedsamplesinﬂuencedtheresults,bothfreshandfrozen
samples, was analyzed using 2D-PAGE. No major diﬀerences
could be detected in the protein expression proﬁles for
any of the diﬀerent solubilization or precipitation methods
(data not shown). An increased number of low molecular
weight proteins were obtained with samples solubilized in
urea/CHAPS precipitated with acidiﬁed acetone (Figure 2,
A5).
These spots were not obtained with other combinations
of solubilizations and precipitations (Figure 3). Electroen-
dosmotic ﬂow (EOF) was detected during the IEF run
with samples precipitated with acetone, acidiﬁed acetone,
or ethanol. This resulted in swelling of the IPG-strip in
the alkaline pH gradient and might cause a poor protein
separation at an isoelectric point above 8.
3.3. Preeclampsia. Urea/CHAPS in combination with either
acidiﬁed acetone or dichloromethane/methanol precipi-
tation was judged to be the most eﬃcient extraction
methods for 2D-PAGE. However, we chose dicholorometh-
ane/methanol since it is known to remove lipids of which6 Journal of Biomedicine and Biotechnology
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Figure 3: Two-dimensional separation of precipitated proteins
(100μg) in PE placenta solubilized in urea/CHAPS. Segments
showdiﬀerentialexpressionpatterninconsequenceofprecipitation
procedures. (a) dichloromethane/methanol, (b) TCA, (c) TCA
followed by ethanol wash, (d) acetone, (e) acidiﬁed acetone, and (f)
ethanol. Circles indicate landmarks for orientation. The gels were
stained with silver.
there is abundance in the placenta. In a ﬁrst attempt
to investigate whether it is possible to detect diﬀerences
between the PE and normal placenta in crude extracts, we
pooled crude placenta extracts from 30preeclamptic and
30normotensive women respectively. In order to decrease
the variation of the diﬀerently expressed proteins on the 2D-
PAGE, three replicates of each pooled group were made. The
number of spots detected was 604 and 747 for preeclamptic
and normotensive, respectively. The number of spots was
calculated based on the criteria that the spots were present
in all triplicate gels in each group. The analysis of the 2D-
PAGE showed that 23proteins were increased and 28 were
decreased in the PE placenta (Figure 4). Two proteins have so
far been identiﬁed with MALDI-TOF MS: apolipoprotein A1
(APOA1)(accnumber:P02647)andtropomyosin-3(TPM3)
(acc number: P06753). APOA1 was 1.63times increased in
the PE placenta pool as compared to the control pool (PE:
10871±1340 optical density (OD) units and controls: 6663±
1772 OD units values presented as mean ± SD). TPM3 was
only found in the normotensive pool.
TheincreasedaccumulationofAPOA1inthePEplacenta
was validated by means of western blot (Figure 5(a)). All
samples, 30PE and 30controls, were run individually. After
measuring the absorption of all the APOA1 bands, APOA1
was found to be 1.18times increased in PE (PE: 63120 ±
14350 optical density (OD) units and controls: 52810 ±
13310 OD units values presented as mean ± SD). The accu-
mulation of APOA1 was signiﬁcantly increased in PE (P =
0.02) (Figure 5(b)). Immunohistochemistry showed APOA1
to be accumulated in trophoblasts. Both normotensive and
PE placenta sections showed a similar pattern with weaker
staining in the control sections (Figures 5(c)–5(e)). The
TPM3expressioncouldnotbevalidatedbymeansofWestern
blot since the recommended antibodies did not work in our
hands (sc-32516 and sc-18174, Santa Cruz Biotechnology,
Santa Cruz, USA).
4. Discussion
Due to the vast number of functions and many diﬀerent cell
typesbesidesthetrophoblasts,includingwhiteandredblood
cells and endothelial cells, the placenta is a complex organ to
study. In order to optimize the protein sample preparation
for 2D-PAGE, we compared two diﬀerent solubilization
solutions in combination with six diﬀerent precipitation
methods in order to obtain maximal separation of the
proteins.
Hepes buﬀer and urea/CHAPS showed diﬀerent protein
patterns in the low molecular mass range. Although no
protease inhibitors were added to the urea/CHAPS solution,
urea denatures and inactivates proteases and thus, it is
unlikely that the diﬀerences are due proteolytic cleavage
[23]. Several steps in the sample preparations appear to
be important to remove contaminating substances. During
pregnancythereisagradualaccumulationofglycogenaswell
as a large amount of lipids in the placenta [15]. Glycogen
and lipids are known to disrupt IEF-separation by blocking
the IPG-strip resulting in no or very few spots on 2D-PAGE.
Hence, the centrifugation step was crucial for the sample
preparation. The centrifugation did not cause a selective loss
of proteins, indicating that most of the placental proteins
remainedinthesupernatant.Thefreezingofsamplesdirectly
after solubilization (without the centrifugation step) resulted
in insoluble aggregates. However, freezing samples after the
centrifugation step did not change the proteome map. This
observationmayfacilitatetheworkﬂowinproteomicswhere
many samples are analyzed, and the samples can be stored in
thefreezeruntilfurtherusewithouthavingamajorinﬂuence
on the results.
Our optimization procedures showed that solubilizing
with urea and CHAPS and precipitating with dichloro-
methane/methanol or acidiﬁed acetone gave the highest
number of spots on a 2D-PAGE. Solubilization with Hepes
buﬀer in combination with dichloromethane/methanol also
gave a high number of spots (Figure 2, B1), although
there was considerably more horizontal streaking. Dichlo-
romethane/methanol has the advantage or also removing
lipids, and since the placenta is rich in lipids, this precip-
itation method may be the preferred choice. Hence, in a
ﬁrst study urea/CHAPS in combination with dichlorometh-
ane/methanolwaschosentoexaminethediﬀerencesbetween
the PE and normotensive placental proteome.
The diﬀerentiating proteins have proven to be hard to
identify due to the low concentration of the proteins in the
diﬀeringspots.Thesameproblemwashighlightedinarecent
preeclamptic proteomic study, where, as a consequence of
low amount of proteins, none of the diﬀerentially expressed
proteins could be identiﬁed [18]. However, we have so far
been able to identify two proteins diﬀering between PE andJournal of Biomedicine and Biotechnology 7
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Figure 4: Two-dimensional separation of pooled proteins from normotensive (a) and PE (b). Circles indicate spots whose amount was
increased in the 2D-PAGE of normotensive and PE samples analyzed with the Ludesi’s software Redﬁn. Arrows show identiﬁed proteins; see
Table 2. The gels were stained with SYPRO Ruby.
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Figure 5: Validation of APOA1 accumulation. (a) A representative scanned image of Western blots for APOA1 (PE: n = 5a n dC :n = 4).
All individual sample extracts were run (PE: n = 30 and C: n = 30). Expected size for APOA1 is 28kDA. Molecular weight markers are
represented by arrows. (b) Box plot for the intensity data for APOA1 as determined by GeneTools, showing the median and the 25th and
75th percentile. APOA1 was signiﬁcantly increased in PE (P = .02) (PE: 62247 (56597–67897) OD units, C: 53551 (48354–58749) OD units.
Both values are presented as mean (95th percentile conﬁdence interval). (c) Representative image for immunohistochemistry on APOA1 on
a PE section. Scale bar = 100μm. (d) Zoomed in image of APOA1 staining in a PE section (from the box in D). APOA1 staining was detected
in trophoblasts (arrow). Scale bar = 30μm. (e) A representative image of a control section. APOA1 staining was weaker than in PE but was
localized in trophoblasts as seen in PE. Scale bar = 100μm.8 Journal of Biomedicine and Biotechnology
controls: APOA1 (increased in PE) and TPM3 (decreased in
PE Figure 4). The increase of APOA1 in PE was validated by
Western blot and immunohistochemistry (Figure 5). Due to
the diﬃculties in identifying low abundance proteins in a
crude extracted sample, one might have to do puriﬁcations
of speciﬁc cell types, for example, trophoblast to explore the
proteome of the placenta [24]. Another limitation with 2D-
PAGE is that membrane proteins do not easily enter IEF, the
ﬁrst dimension since they often precipitate in the IPG-strip.
In our ﬁrst attempt to study diﬀerences between PE and
normotensive placenta, we found apolipoprotein A1, a lipid
binding protein, to be accumulated in the PE placenta. Of
the lipoproteins, APOA1 is mainly synthesized in the liver
and intestines and is the major fraction of the high-density
lipoproteins [25]. The placenta has also been suggested as a
site of synthesis for APOA1 although it is not clear whether
this is an actual de novo synthesis or an accumulation from
the blood stream. In a recent whole genome microarray
analysis, increased APOA1 gene expression was not detected
in the PE placenta. It is unlikely that the accumulation of
APOA1 in the PE placenta is due to high levels of APOA1
in the maternal plasma since plasma levels APOA1 are not
increased in PE [26, 27]. In a recent proteomics study of
amniotic ﬂuid, accumulation of pro-APOA1 was shown in
the amniotic ﬂuid in PE [28]. Hence, amniotic ﬂuid may be a
possible source of the accumulated APOA1 seen in the PE
placenta. How the accumulation of APOA1 aﬀects the PE
placenta is unknown. APOA1 may server either as nutrient
or as a signaling molecule by aﬀecting biological signaling
pathways such as protein kinase C dependent pathway
(PKC and the mitogen-activated protein kinases (MAPK)
[29, 30].
In conclusion, two solubilization methods in combi-
nation with six diﬀerent precipitation procedures were
tested. Several steps in the sample preparation appear
important. Removal of glycogen by centrifugation is
crucial since the glycogen clogged the IPG-strip. Both
the solubilization solution and the precipitation proce-
dure aﬀected the placenta proteome maps. In this study,
solubilization with urea/CHAPS in combination with
dichloromethane/methanol or acidiﬁed acetone proved to
be the best precipitation procedures, resulting in more
spots and less streaking on 2D-PAGE. Importantly, freezing
samples following centrifugation of the solubilized samples
did not aﬀect the proteome map. However, due to the
limitation using crude extracts for 2D-PAGE, low abundance
proteins cannot readily be detected, and thus subcellular
fractioning may be required to fully investigate the placenta
proteome.
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